These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34330301)

  • 1. Genetic alterations and functional networks of m6A RNA methylation regulators in pancreatic cancer based on data mining.
    Zeng J; Zhang H; Tan Y; Wang Z; Li Y; Yang X
    J Transl Med; 2021 Jul; 19(1):323. PubMed ID: 34330301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The N6-Methyladenosine- (m6A-) Associated Genes Act as Strong Key Biomarkers for the Prognosis of Pancreatic Adenocarcinoma.
    Li F; Zhang P
    Comput Math Methods Med; 2021; 2021():8715823. PubMed ID: 34840598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m6A regulators are differently expressed and correlated with immune response of pancreatic adenocarcinoma.
    Zhang T; Sheng P; Jiang Y
    J Cancer Res Clin Oncol; 2023 Jul; 149(7):2805-2822. PubMed ID: 35780396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
    Guo Y; Wang R; Li J; Song Y; Min J; Zhao T; Hua L; Shi J; Zhang C; Ma P; Yang C; Zhu L; Gan D; Li S; Liu X; Su H
    Front Immunol; 2021; 12():769425. PubMed ID: 34804059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of m6A-related genes and m6A RNA methylation regulators in pancreatic cancer and their association with survival.
    Geng Y; Guan R; Hong W; Huang B; Liu P; Guo X; Hu S; Yu M; Hou B
    Ann Transl Med; 2020 Mar; 8(6):387. PubMed ID: 32355831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene Alterations of N6-Methyladenosine (m
    Zhang Q; Cai Y; Kurbatov V; Khan SA; Lu L; Zhang Y; Johnson CH
    Biomed Res Int; 2020; 2020():8826456. PubMed ID: 33415160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
    Jiao J; Jiang L; Luo Y
    Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IGF2BP2 promotes pancreatic carcinoma progression by enhancing the stability of B3GNT6 mRNA via m6A methylation.
    Cao P; Wu Y; Sun D; Zhang W; Qiu J; Tang Z; Xue X; Qin L
    Cancer Med; 2023 Feb; 12(4):4405-4420. PubMed ID: 35908253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer.
    Chen M; Nie ZY; Wen XH; Gao YH; Cao H; Zhang SF
    Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31808521
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of N6-Methyladenosine RNA Methylation Regulators in Immune Infiltrates of Ovarian Cancer.
    Gu J; Bi F
    Front Genet; 2021; 12():671179. PubMed ID: 34306015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrations of m6A regulators are associated with tumorigenesis and metastasis in head and neck squamous cell carcinoma.
    Arumugam P; George R; Jayaseelan VP
    Arch Oral Biol; 2021 Feb; 122():105030. PubMed ID: 33383437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
    Han X; Liu J; Cheng G; Cui S
    Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune infiltration-related N6-methyladenosine RNA methylation regulators influence the malignancy and prognosis of endometrial cancer.
    Ma J; Yang D; Ma XX
    Aging (Albany NY); 2021 Jun; 13(12):16287-16315. PubMed ID: 34230220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic values of m6A RNA methylation regulators in differentiated Thyroid Carcinoma.
    Xu N; Chen J; He G; Gao L; Zhang D
    J Cancer; 2020; 11(17):5187-5197. PubMed ID: 32742465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic analysis of molecular characterization and clinical relevance of m6A regulators in digestive system pan-cancers.
    Kou T; Chai R; Jin L; Bai Z; Yang Y; Zhao Y; Wu D; Zhang Z; Yang Y
    Exp Biol Med (Maywood); 2021 Sep; 246(18):2007-2018. PubMed ID: 34102905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Four m6A RNA Methylation Gene Signatures and Their Prognostic Values in Lung Adenocarcinoma.
    Wang Y; Zhao X; Li J; Wang X; Hu W; Zhang X
    Technol Cancer Res Treat; 2022; 21():15330338221085373. PubMed ID: 35343834
    [No Abstract]   [Full Text] [Related]  

  • 17. Systematic analysis of the expression profile and prognostic significance of m6A regulators and PD-L1 in hepatocellular carcinoma.
    Kong F; Wang K; Wang L
    Discov Oncol; 2022 Nov; 13(1):131. PubMed ID: 36434140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. m6A RNA methylation regulators were associated with the malignancy and prognosis of ovarian cancer.
    Zhang C; Liu J; Guo H; Hong D; Ji J; Zhang Q; Guan Q; Ren Q
    Bioengineered; 2021 Dec; 12(1):3159-3176. PubMed ID: 34187307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Prognostic Characteristics of m6A RNA Methylation Regulators in Colon Cancer.
    Huang L; Zhu J; Kong W; Li P; Zhu S
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IGF2BP2 serves as a core m6A regulator in head and neck squamous cell carcinoma.
    Hu Y; Chen J; Liu M; Feng Q; Peng H
    Biosci Rep; 2022 Nov; 42(11):. PubMed ID: 36281789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.